1201 related articles for article (PubMed ID: 19009984)
21. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
22. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
24. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
[TBL] [Abstract][Full Text] [Related]
25. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Fu X; Liu H; Zhang F
Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
[No Abstract] [Full Text] [Related]
26. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
[No Abstract] [Full Text] [Related]
27. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
Katoch K; Natarajan M; Bagga A; Katoch VM
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
Wabitsch KR; Meyers WM
Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
[No Abstract] [Full Text] [Related]
29. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
30. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
31. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
32. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
34. Presence of Mycobacterium leprae in epidermal cells of lepromatous skin and its significance.
Satapathy J; Kar BR; Job CK
Indian J Dermatol Venereol Leprol; 2005; 71(4):267-9. PubMed ID: 16394437
[TBL] [Abstract][Full Text] [Related]
35. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
36. Silent iritis in treated bacillary negative leprosy.
Thompson K; Job CK
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
[TBL] [Abstract][Full Text] [Related]
37. Leprosy in a Mexican immigrant.
Baker B; Evans M; DeCastro F; Schosser R
J Ky Med Assoc; 2003 Jul; 101(7):289-94. PubMed ID: 12886712
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
39. Incidence of "chance" smear positivity among MB leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Indian J Lepr; 1995; 67(3):249-58. PubMed ID: 8576604
[TBL] [Abstract][Full Text] [Related]
40. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
